Results 211 to 220 of about 8,412,464 (305)

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study

Hepatology Research, EarlyView.
We conducted a multicenter cohort study analyzed 454 Japanese PBC patients. Baseline LSM ≥ 8.0 kPa was independently associated with adverse outcomes. ΔLSM/year ≥ 2.1 kPa was independently associated with adverse outcomes. ABSTRACT Background & Aims Liver stiffness measurement (LSM) using vibration‐controlled transient elastography (VCTE) is a ...
Yuki Yamashita, Takefumi Kimura, Kaede Fujita, Taiki Okumura, Takanobu Iwadare, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Masanori Abe, Akinobu Takaki, Kazumichi Abe, Masaaki Takamura, Tadashi Namisaki, Yuki Kugiyama, Atsumasa Komori, Atsushi Tanaka   +17 more
wiley   +1 more source

The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus. [PDF]

Hepatol Commun
Majumdar A, Holmes J, Roberts SK, Bhat P, Mitchell T, Ramachandran J, O'Beirne J, Walker S, Sawhney R, Jagarlamudi N, Jacob R, Gill M, Thomas JA, Thomas JA, Bloom S, Gracen L, Kemp W, Raj A, Thompson AJ, Romero S, Doyle A, Maher A, Pow R, Robertson M, Tiwari N, Tibballs J, Lubel J, Popuri R, Testro A, Valliani T, Waller K, Chapman B, Gupta R, Hey P, Keating S, Sinclair M, Janko N, Koshy A, Majeed A, Mohammadi F, Fergusson J, Furtado R, MacQuillan G, Muller K, Santhakumar C, Ahlenstiel G, Strasser SI.   +46 more
europepmc   +1 more source

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study

Hepatology Research, EarlyView.
ABSTRACT Aim To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Hirohito Osanai, Kazuto Kozaka, Takashi Matsubara, Norihide Yoneda, Takahiro Ogi, Kenichiro Okumura, Atsushi Takamatsu, Azusa Kitao, Shintaro Yagi, Taro Yamashita, Satoshi Kobayashi   +10 more
wiley   +1 more source

Ten-year progression of Caroli's disease with portal hypertension despite endoscopic and pharmacological therapy: Implications for liver transplantation-A case report. [PDF]

SAGE Open Med Case Rep
Meng H, Xie R, Yang C.
europepmc   +1 more source

Recombinant ADAMTS13 Ameliorates Liver Injury and Improves Hepatic Microcirculation in a Murine Acute‐on‐Chronic Liver Failure Model

Hepatology Research, EarlyView.
ABSTRACT Aim The therapeutic significance of recombinant a disintegrin‐like and metalloprotease with thrombospondin type 1 motif 13 (rADAMTS13) in acute‐on‐chronic liver failure (ACLF) remains unclear. We aimed to investigate the therapeutic effects of rADAMTS13 in a murine model of ACLF‐like liver injury.
Jun‐ichi Hanatani, Norihisa Nishimura, Kosuke Kaji, Masayoshi Takami, Hiroyuki Masuda, Hiroaki Takaya, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji   +9 more
wiley   +1 more source

When Portal Hypertension Conceals a Gastric Neuroendocrine Tumor: A Rare Mimic of Decompensated Chronic Liver Disease. [PDF]

Cureus
Rathod SH, Patel Y, Sankar A, Dhar M, Durgapal P.   +4 more
europepmc   +1 more source

Validation of the Baveno Endoscopy Avoidance Criteria in Japanese Patients With Chronic Liver Disease: A Real‐World Cohort Study

Hepatology Research, EarlyView.
Many patients with chronic liver disease can safely avoid unnecessary screening endoscopy using the Baveno VII criteria. We developed a simple three‐factor score to identify patients at high risk of serious esophageal varices. Using both approaches together may improve the efficiency and safety of endoscopic screening.
Maiko Asami, Yoshihito Uchida, Shohei Tsuji, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida   +9 more
wiley   +1 more source

Clinically Diagnosed Decompensated Chronic Liver Disease With Suspected Portal Hypertension in a One-Year-Old Infant: Diagnostic Challenges in a Resource-Limited Setting. [PDF]

Clin Case Rep
Ibrahim KJ, Ali AMH, Omer NI, Elmi OA.
europepmc   +1 more source

Cisterna Chyli Dilation Is a Risk Factor for Liver Nodules and Hepatocellular Carcinoma in Fontan‐Associated Liver Disease: Pathophysiological Role of Lymphatic Dysfunction

Hepatology Research, EarlyView.
ABSTRACT Aim In Fontan‐associated liver disease (FALD), chronic congestion often confounds conventional fibrosis markers, complicating surveillance for hepatocellular carcinoma (HCC). Although lymphatic dysfunction is fundamental to Fontan physiology, its contribution to hepatocarcinogenesis remains unclear.
Koji Imoto, Masatake Tanaka, Takeshi Goya, Yuuki Azuma, Tomonobu Hioki, Yusuke Morita, Keisuke Sakaguchi, Nobuhiro Fujita, Takamori Kakino, Ayako Ishikita, Kenichiro Yamamura, Ichiro Sakamoto, Kousei Ishigami, Kohtaro Abe, Yoshihiro Ogawa   +14 more
wiley   +1 more source

Multifocal autoimmune pancreatitis complicated by pancreatic insufficiency and segmental portal hypertension: A case report and review of the literature. [PDF]

Radiol Case Rep
Ennejjari N, Abouchiba S, Abdourabbih Y, Chaouche I, Chahdi HO, Akammar A, El Bouardi N, Alami B, Boubbou M, Maaroufi M, Lamrani MYA.   +10 more
europepmc   +1 more source